The impact of pharmaceutical box on medication adherence in patients treated with warfarin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016010914229N4

Enrollment

Registered

2016-02-03

Start date

2015-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug adherence. Drug use

Interventions

Intervention 1: Group 1 (intervention) using medication reminder box to warfarin for 30 days. Intervention 2: Group 2 (control): In this group, do not interfere.

Prevention

Group 1 (intervention) using medication reminder box to warfarin for 30 days

Group 2 (control): In this group, do not interfere.

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included: cardiovascular disease approved by the doctor; taking warfarin; ability to use of drugs; having aged between 40 and 60 years. Exclusion criteria included: Failure to provide complete information; incomplete questionnaires: unwillingness to provide blood samples for testing; and any physical or mental disability.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Drug adherence. Timepoint: Before and after 30 days. Method of measurement: Medication Adherence Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Jafari Manesh

Arak University of Medical Sciences

nurse_science@yahoo.com+98 86 3417 3503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026